drinking and semaglutide GLP-1 medications: The next big thing in alcohol use disorder treatment? – Recovery Research Institute Semaglutide and tirzepatide decrease cravings

In addition to the above findings, several studies have shown that GLP-1RA therapy results in larger proportions of patients achieving 5% and 10% body weight loss than with placebo (Table 1)

Track protein intake

dose increases or alternating with complementary compounds like tirzepatide often restores effectiveness

Discontinuation Strategies and Maintenance Protocols Evidence supports several approaches to minimize weight regain: gradual dose tapering over weeks to months (rather than abrupt cessation), concurrent lifestyle intensification (structured nutrition and exercise), and consideration of alternative medications or lower-dose maintenance therapy

Tyna Moore on Health Coach Talk. We do a deep dive into these medications and particularly how, as a coach, you can work with them